-+ 0.00%
-+ 0.00%
-+ 0.00%

Sunshine Biopharma wins Canadian approval for generic amoxicillin

PUBT·05/21/2026 11:00:54
Listen to the news
Sunshine Biopharma wins Canadian approval for generic amoxicillin
  • Sunshine Biopharma received Canadian regulatory clearance for its generic amoxicillin, expanding its antibiotics portfolio into Canada.
  • Product shipments to pharmacies are targeted for August 2026.
  • Amoxicillin generated an estimated USD 4.9 billion to USD 5.9 billion in global sales in 2025; Canada represents about 2% of the market.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sunshine Biopharma Inc. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 202605210700ACCESSWRNAPR_____1169035) on May 21, 2026, and is solely responsible for the information contained therein.